TY - JOUR
T1 - A Novel Fluorescence-Based Screen for Inhibitors of the Initiation of DNA Replication in Bacteria
AU - Klitgaard, Rasmus N.
AU - Løbner-Olesen, Anders
N1 - Copyright© Bentham Science Publishers; For any queries, please email at [email protected].
PY - 2019
Y1 - 2019
N2 - Background: One of many strategies to overcome antibiotic resistance is the discovery of compounds targeting cellular processes, which have not yet been exploited. Materials and Methods: Using various genetic tools, we constructed a novel high throughput, cellbased, fluorescence screen for inhibitors of chromosome replication initiation in bacteria. Results: The screen was validated by expression of an intra-cellular cyclic peptide interfering with the initiator protein DnaA and by over-expression of the negative initiation regulator SeqA. We also demonstrated that neither tetracycline nor ciprofloxacin triggers a false positive result. Finally, 400 extracts isolated mainly from filamentous actinomycetes were subjected to the screen. Conclusion: We concluded that the presented screen is applicable for identifying putative inhibitors of DNA replication initiation in a high throughput setup.
AB - Background: One of many strategies to overcome antibiotic resistance is the discovery of compounds targeting cellular processes, which have not yet been exploited. Materials and Methods: Using various genetic tools, we constructed a novel high throughput, cellbased, fluorescence screen for inhibitors of chromosome replication initiation in bacteria. Results: The screen was validated by expression of an intra-cellular cyclic peptide interfering with the initiator protein DnaA and by over-expression of the negative initiation regulator SeqA. We also demonstrated that neither tetracycline nor ciprofloxacin triggers a false positive result. Finally, 400 extracts isolated mainly from filamentous actinomycetes were subjected to the screen. Conclusion: We concluded that the presented screen is applicable for identifying putative inhibitors of DNA replication initiation in a high throughput setup.
U2 - 10.2174/1570163815666180423115514
DO - 10.2174/1570163815666180423115514
M3 - Journal article
C2 - 29683093
SN - 1570-1638
VL - 16
SP - 272
EP - 277
JO - Current Drug Discovery Technologies
JF - Current Drug Discovery Technologies
IS - 3
ER -